Pacira Pharmaceuticals's market cap is currently $1.19B. The company's EPS TTM is $-2.051; its P/E ratio is ―; Pacira Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $0.83. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 674.98M	$ 666.82M	$ 541.53M	$ 420.83M	$ 421.03M
Gross Profit	$ 490.31M	$ 467.53M	$ 401.28M	$ 303.50M	$ 314.31M
Operating Income	$ 87.67M	$ 60.02M	$ 131.06M	$ 46.35M	$ 38.11M
EBITDA	$ 157.58M	$ 144.78M	$ 118.47M	$ 71.42M	$ 55.29M
Net Income	$ 41.95M	$ 15.91M	$ 41.98M	$ 145.52M	$ -11.02M
Balance Sheet
Cash & Short-Term Investments	$ 278.58M	$ 288.65M	$ 656.41M	$ 521.66M	$ 291.95M
Total Assets	$ 1.57B	$ 1.68B	$ 2.08B	$ 1.27B	$ 831.07M
Total Debt	$ 586.04M	$ 763.39M	$ 1.13B	$ 541.13M	$ 351.92M
Net Debt	$ 432.75M	$ 659.25M	$ 543.27M	$ 441.17M	$ 273.69M
Total Liabilities	$ 704.26M	$ 906.19M	$ 1.34B	$ 654.83M	$ 476.12M
Stockholders' Equity	$ 870.13M	$ 775.01M	$ 730.41M	$ 619.69M	$ 354.94M
Cash Flow
Free Cash Flow	$ 139.49M	$ 115.20M	$ 79.85M	$ 39.23M	$ 60.36M
Operating Cash Flow	$ 154.65M	$ 145.27M	$ 125.72M	$ 77.03M	$ 70.52M
Investing Cash Flow	$ 77.54M	$ -225.19M	$ -20.79M	$ -277.61M	$ -128.49M
Financing Cash Flow	$ -183.03M	$ -401.53M	$ 380.69M	$ 222.30M	$ 3.67M

Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History

Income Statement >

Pacira Pharmaceuticals Debt to Assets

Balance Sheet >

Pacira Pharmaceuticals Cash Flow

Cash Flow >

Pacira Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing